 |
|
|
| |
Brelovitug (BJT-778) Monotherapy Achieved 100% Virologic Response in Patients with Chronic Hepatitis D: On Treatment Week 48 Phase 2 Study Results
|
| |
| |
AASLD 2025 Nov 7-11 Wash DC
Kosh Agarwal, Alina Jucov, Marta Dobryanska, Patrick Kennedy, Edward J. Gane, Man-Fung Yuen, Grace Lai-Hung Wong, Simone Strasser, Jacinta Holmes, Stuart Roberts, Hassan Javanbakht, Nancy Shulman, Susanna K. Tan
|
| |
|
|
|
|
|
